Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Région de Kantō163
Takato Odagiri11
Région de Kantō Sauf Takato Odagiri" 153
Takato Odagiri Sauf Région de Kantō" 1
Région de Kantō Et Takato Odagiri 10
Région de Kantō Ou Takato Odagiri 164
Corpus10482
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000911 Emi Takashita [Japon] ; Miho Ejima [Japon] ; Rie Ogawa [Japon] ; Seiichiro Fujisaki [Japon] ; Gabriele Neumann [États-Unis] ; Yousuke Furuta [Japon] ; Yoshihiro Kawaoka [Japon] ; Masato Tashiro [Japon] ; Takato Odagiri [Japon]Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
002215 Nongluk Sriwilaijaroen [Thaïlande, Japon] ; Syuichi Fukumoto [Japon] ; Kenji Kumagai [Japon] ; Hiroaki Hiramatsu [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Yasuo Suzuki [Japon]Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1 N1 viruses: Its role in viral hemagglutination and neuraminidase inhibition
002B26 Mina Nakauchi [Japon] ; Makoto Ujike [Japon] ; Masatsugu Obuchi [Japon] ; Emi Takashita [Japon] ; Ikuyo Takayama [Japon] ; Miho Ejima [Japon] ; Kunihiro Oba [Japon] ; Nami Konomi [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Tsutomu Kageyama [Japon]Rapid Discrimination of Oseltamivir-Resistant 275Y and -Susceptible 275H Substitutions in the Neuraminidase Gene of Pandemic Influenza A/H1N1 2009 Virus by Duplex One-Step RT-PCR Assay
002C70 Yuichi Harada [Japon] ; Ai Ninomiya-Mori [Japon] ; Yoshimasa Takahashi [Japon] ; Masayuki Shirakura [Japon] ; Noriko Kishida [Japon] ; Tsutomu Kageyama [Japon] ; Yoshikazu Tada [Japon] ; Masato Tashiro [Japon] ; Takato Odagiri [Japon]Inactivated and adjuvanted whole-virion clade 2.3.4 H5N1 pre-pandemic influenza vaccine possesses broad protective efficacy against infection by heterologous clades of highly pathogenic H5N1 avian influenza virus in mice
003901 Takeshi Ichinohe [Japon] ; Akira Ainai [Japon] ; Yasushi Ami [Japon] ; Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Akira Kawaguchi [Japon] ; Yuriko Suzaki [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Hidehiro Takahashi [Japon] ; David R. Strayer [États-Unis] ; William A. Carter [États-Unis] ; Joe Chiba [Japon] ; Shin-Ichi Tamura [Japon] ; Tetsutaro Sata [Japon] ; Takeshi Kurata [Japon] ; Hideki Hasegawa [Japon]Intranasal Administration of Adjuvant-Combined Vaccine Protects Monkeys From Challenge With the Highly Pathogenic Influenza A H5N1 Virus
003B10 Yuma Iwai [Japon] ; Hitoshi Takahashi [Japon] ; Dai Hatakeyama [Japon] ; Kazunori Motoshima [Japon] ; Minoru Ishikawa [Japon] ; Kazuyuki Sugita [Japon] ; Yuichi Hashimoto [Japon] ; Yuichi Harada [Japon] ; Shigeyuki Itamura [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Yoshihisa Sei [Japon] ; Kentaro Yamaguchi [Japon] ; Takashi Kuzuhara [Japon]Anti-influenza activity of phenethylphenylphthalimide analogs derived from thalidomide
004473 Daisuke Ikeno [Japon] ; Kazuhiko Kimachi [Japon] ; Yasuhiro Kudo [Japon] ; Shuro Goto [Japon] ; Shigeyuki Itamura [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Yoichiro Kino [Japon]A prime-boost vaccination of mice with heterologous H5N1 strains
004C04 Takeshi Ichinohe [Japon] ; Noriyo Nagata [Japon] ; Peter Strong [Royaume-Uni] ; Shin-Ichi Tamura [Japon] ; Hidehiro Takahashi [Japon] ; Ai Ninomiya [Japon] ; Masaki Imai [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Hirofumi Sawa [Japon] ; Joe Chiba [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus
004E75 Takeshi Ichinohe [Japon] ; Shin-Ichi Tamura [Japon] ; Akira Kawaguchi [Japon] ; Ai Ninomiya [Japon] ; Masaki Imai [Japon] ; Shigeyuki Itamura [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Hidehiro Takahashi [Japon] ; Hirofumi Sawa [Japon] ; William M. Mitchell [États-Unis] ; David R. Strayer [États-Unis] ; William A. Carter [États-Unis] ; Joe Chiba [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine
005339 Taisuke Horimoto [Japon] ; Ayato Takada [Japon] ; Ken Fujii [Japon] ; Hideo Goto [Japon] ; Masato Hatta [États-Unis] ; Shinji Watanabe [États-Unis] ; Kiyoko Iwatsuki-Horimoto [Japon] ; Mutsumi Ito [Japon] ; Yuko Tagawa-Sakai [Japon] ; Shinya Yamada [Japon] ; Hirotoshi Ito [Japon] ; Toshihiro Ito [Japon] ; Masaki Imai [Japon] ; Shigeyuki Itamura [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Wilina Lim [Hong Kong] ; YI GUAN [Hong Kong] ; Malik Peiris [Hong Kong] ; Yoshihiro Kawaoka [Japon, États-Unis]The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021